Ares Capital: No Evidence Of SaaS Pain
Ares Capital (ARCC) maintains strong financial health despite broader concerns about SaaS loan performance in the private credit market. The company supports a 10% dividend yield through solid net investment income and a high-quality loan portfolio. Portfolio growth continued in Q1'26 with a 9% year-over-year increase and a low 1.2% non-accrual ratio. Given its stable performance, ARCC remains a 'Hold' recommendation for income-focused investors.
- ▪Ares Capital trades at a discount to net asset value due to AI-driven sector pessimism rather than company-specific issues.
- ▪The 10% dividend yield is fully covered by net investment income, indicating sustainable distributions.
- ▪ARCC's loan portfolio saw 9% year-over-year growth in Q1'26 with a minimal 1.2% non-accrual rate.
- ▪Despite concerns about SaaS lending, ARCC shows no signs of material credit deterioration.
- ▪The article maintains a 'Hold' rating on ARCC, citing strong underwriting and portfolio quality.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Earnings Analysis","item":"https://seekingalpha.com/earnings/earnings-analysis"},{"@type":"ListItem","position":3,"name":"Financials ","item":"https://seekingalpha.com/stock-ideas/financial"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4895518-ares-capital-no-evidence-of-saas-pain"},"author":{"@type":"Person","name":"The Asian…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
